Rhumbline Advisers Astellas Pharma Inc Unsponsore Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Astellas Pharma Inc Unsponsore stock. As of the latest transaction made, Rhumbline Advisers holds 36,828 shares of ALPMY stock, worth $371,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,828
Previous 33,588 9.65%
Holding current value
$371,594
Previous $331,000 27.49%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$9.81 - $12.64 $31,784 - $40,953
3,240 Added 9.65%
36,828 $422,000
Q2 2024

Aug 01, 2024
SELL
$9.27 - $10.79 $40,194 - $46,785
-4,336 Reduced 11.43%
33,588 $331,000
Q1 2024

May 09, 2024
BUY
$10.62 - $12.28 $37,010 - $42,795
3,485 Added 10.12%
37,924 $407,000
Q4 2023

Feb 08, 2024
SELL
$11.36 - $13.81 $3,635 - $4,419
-320 Reduced 0.92%
34,439 $409,000
Q3 2023

Nov 09, 2023
BUY
$13.85 - $15.55 $207 - $233
15 Added 0.04%
34,759 $481,000
Q2 2023

Aug 08, 2023
BUY
$14.05 - $16.79 $488,153 - $583,351
34,744 New
34,744 $516,000

Others Institutions Holding ALPMY

# of Institutions
5
Shares Held
208K
Call Options Held
0
Put Options Held
0
View Full List

About Astellas Pharma Inc Unsponsore

ALPMY Quotes by TradingView
  • Ticker ALPMY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,827,069,952
  • Market Cap $18.4B
More about ALPMY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email